ITF 1096
Latest Information Update: 31 May 1996
At a glance
- Originator Italfarmaco
- Class Antianaemics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anaemia
Most Recent Events
- 31 May 1996 Discontinued-I for Anaemia in Italy (Unknown route)